相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of RNAi-induced down regulation of nuclear factor kappa-B p65 on acute monocytic leukemia THP-1 cells in vitro and vivo
Chunmei Wang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2012)
Isothiocyanates induce oxidative stress and suppress the metastasis potential of human non-small cell lung cancer cells
Xiang Wu et al.
BMC CANCER (2010)
Role of NF-κB in thyroid cancer
Francesco Pacifico et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Standard and Emerging Therapies for Metastatic Differentiated Thyroid Cancer
Christine J. O'Neill et al.
ONCOLOGIST (2010)
Suppression of human hepatoma (HepG2) cell growth by nuclear factor-kappaB/p65 specific siRNA
Wei Wu et al.
TUMOR BIOLOGY (2010)
Thyrotoxicosis Due to Functioning Metastatic Follicular Thyroid Carcinoma After Twelve I-131 Therapies
Jian Tan et al.
CLINICAL NUCLEAR MEDICINE (2009)
New therapeutic advances in the management of progressive thyroid cancer
Jennifer A. Woyach et al.
ENDOCRINE-RELATED CANCER (2009)
OPINION Is NF-κB a good target for cancer therapy? Hopes and pitfalls
Veronique Baud et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Dehydroxymethylepoxyquinomicin, a Novel Nuclear Factor-κB Inhibitor, Enhances Antitumor Activity of Taxanes in Anaplastic Thyroid Cancer Cells
Zhaowei Meng et al.
ENDOCRINOLOGY (2008)
Refractory thyroid cancer: A paradigm shift in treatment is not far off
David G. Pfister et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Nuclear Factor-κB in thyroid carcinogenesis and progression:: A novel therapeutic target for advanced thyroid cancer
Hiroyuki Namba et al.
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA (2007)
Nuclear factor-kappa B p65 small interfering RNA or proteasome inhibitor bortezomib sensitizes head and neck squamous cell carcinomas to classic histone deacetylase inhibitors and novel histone deacetylase inhibitor PXD101
Jianming Duan et al.
MOLECULAR CANCER THERAPEUTICS (2007)
BRAFV600E promotes invasiveness of thyroid cancer cells through nuclear factor κB activation
Iryna Palona et al.
ENDOCRINOLOGY (2006)
Antitumor effects of the proteasome inhibitor bortezomib in medullary and anaplastic thyroid carcinoma cells in vitro
Constantine S. Mitsiades et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: Benefits and limits of radioiodine therapy
C. Durante et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Nuclear factor-κB in cancer development and progression
Michael Karin
NATURE (2006)
Increasing incidence of thyroid cancer in the United States, 1973-2002
L Davies et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Cell death induced by 131I in a differentiated thyroid carcinoma cell line in vitro:: Necrosis or apoptosis?
K Marx et al.
NUCLEAR MEDICINE COMMUNICATIONS (2006)
Survival and death causes in differentiated thyroid carcinoma
CFA Eustatia-Rutten et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Oncogenic and anti-apoptotic activity of NF-κB in human thyroid carcinomas
F Pacifico et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Inhibition of nuclear factor-kappa B cascade potentiates the effect of a combination treatment of anaplastic thyroid cancer cells
D Starenki et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Induction of thyroid cancer cell apoptosis by a novel nuclear factor κB inhibitor, dehydroxymethylepoxyquinomicin
DV Starenki et al.
CLINICAL CANCER RESEARCH (2004)
Enhanced chemosensitivity to irinotecan by RNA interference mediated down-regulation of the nuclear factor-κB p65 subunit
J Guo et al.
CLINICAL CANCER RESEARCH (2004)
To be, or not to be:: NF-κB is the answer -: role of Rel/NF-κB in the regulation of apoptosis
J Kucharczak et al.
ONCOGENE (2003)
分享论文
